SAB Biotherapeutics, Inc. Share Price & Technical Analysis
SABS · $3.90 (+2.36%)
Healthcare / Biotechnology
$3.90
+2.36%
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes i…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
5% return in May, -9% avg return in past 3 year May month.
9% return in 2026, 16% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 16% | -7% | -3% | -3% | 5% | – | – | – | – | – | – | – | 9% |
| 25 | -42% | -23% | -18% | 21% | 12% | -5% | 12% | 11% | -5% | 60% | 25% | -7% | 40% |
| 24 | -14% | -22% | 0% | -4% | -37% | 19% | 0% | 4% | -10% | 22% | -12% | 27% | -28% |
| 23 | 3% | -6% | -32% | 80% | -1% | -8% | 3% | -10% | -17% | 56% | -3% | -29% | 36% |
| 22 | -27% | -15% | -22% | -31% | -22% | -32% | -28% | -40% | -8% | 20% | 16% | -46% | -234% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Uptrend · Uptrend
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$249.48M
P/E ratio
—
52W high
$6.60
52W low
$1.60
Volume
3,26,176
Beta
0.56
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is SAB Biotherapeutics, Inc. share price today?
- SAB Biotherapeutics, Inc. (SABS) last traded around $3.90 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SABS have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SABS. Download the app for real-time alerts.
- How can I analyze SAB Biotherapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.